Chappell KJ, Mordant FL, Li Z, Wijesundara DK, et al. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis 2021 Apr 19. pii: S1473-3099(21)00200.
PMID: 33887208